Mark James Litton - Net Worth and Insider Trading
Mark James Litton Net Worth
The estimated net worth of Mark James Litton is at least $3 Million dollars as of 2024-11-29. Mark James Litton is the Chief Business Officer of Alder BioPharmaceuticals Inc and owns about 128,189 shares of Alder BioPharmaceuticals Inc (ALDR) stock worth over $2 Million. Mark James Litton is also the President and CEO of Athira Pharma Inc and owns about 179,054 shares of Athira Pharma Inc (ATHA) stock worth over $116,922. Details can be seen in Mark James Litton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark James Litton has not made any transactions after 2024-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark James Litton
Mark James Litton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark James Litton owns 3 companies in total, including Athira Pharma Inc (ATHA) , Alpine Immune Sciences Inc (ALPN) , and Alder BioPharmaceuticals Inc (ALDR) .
Click here to see the complete history of Mark James Litton’s form 4 insider trades.
Insider Ownership Summary of Mark James Litton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATHA | Athira Pharma Inc | 2024-09-05 | Chief Operating Officer |
| ALPN | Alpine Immune Sciences Inc | 2018-08-06 | See Remarks |
| ALDR | Alder BioPharmaceuticals Inc | 2018-06-01 | Chief Business Officer |
Mark James Litton Latest Holdings Summary
Mark James Litton currently owns a total of 2 stocks. Among these stocks, Mark James Litton owns 128,189 shares of Alder BioPharmaceuticals Inc (ALDR) as of June 1, 2018, with a value of $2 Million and a weighting of 95.39%. Mark James Litton also owns 179,054 shares of Athira Pharma Inc (ATHA) as of September 5, 2024, with a value of $116,922 and a weighting of 4.61%.
Latest Holdings of Mark James Litton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALDR | Alder BioPharmaceuticals Inc | 2018-06-01 | 128,189 | 18.88 | 2,420,208 |
| ATHA | Athira Pharma Inc | 2024-09-05 | 179,054 | 0.65 | 116,922 |
Holding Weightings of Mark James Litton
Mark James Litton Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark James Litton has made a total of 0 transactions in Alder BioPharmaceuticals Inc (ALDR) over the past 5 years. The most-recent trade in Alder BioPharmaceuticals Inc is the sale of 22,727 shares on June 1, 2018, which brought Mark James Litton around $405,450.
According to the SEC Form 4 filings, Mark James Litton has made a total of 4 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Athira Pharma Inc is the sale of 5,032 shares on September 5, 2024, which brought Mark James Litton around $2,868.
Insider Trading History of Mark James Litton
- 1
Mark James Litton Trading Performance
Mark James Litton Ownership Network
Mark James Litton Owned Company Details
What does Athira Pharma Inc do?
Who are the key executives at Athira Pharma Inc?
Mark James Litton is the Chief Operating Officer of Athira Pharma Inc. Other key executives at Athira Pharma Inc include See Below Andrew Gengos , Vice President of Discovery Kevin Church , and Chief Technology Officer Rachel Lenington .
Athira Pharma Inc (ATHA) Insider Trades Summary
Over the past 18 months, Mark James Litton made 3 insider transaction in Athira Pharma Inc (ATHA) with a net sale of 14,672. Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net purchase of 77,532 shares made by Andrew Gengos , a net sale of 7,349 shares made by Rachel Lenington , and a net sale of 7,349 shares made by Mark Worthington .
In summary, during the past 3 months, insiders sold 13,879 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 13,879 shares. During the past 18 months, 36,787 shares of Athira Pharma Inc (ATHA) were sold and 728,098 shares were bought by its insiders, resulting in a net purchase of 691,311 shares.
Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athira Pharma Inc Insider Transactions
Mark James Litton Mailing Address
Above is the net worth, insider trading, and ownership report for Mark James Litton. You might contact Mark James Litton via mailing address: 11804 North Creek Parkway South, Bothell Wa 98011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
